27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
In an interesting SEC FCPA settlement action, Sridhar Thiruvengadam, the former COO of Cognizant Tec...
Read More >
The National Labor Relations Board (NLRB) has revisited the issue of when an employer may restrict a...
Read More >
In February 2012, an Invenergy affiliate named California Ridge Wind Energy LLC (“California Ridge”...
Read More >
The evening of April 22, Governor Wolf presented his detailed plan for reopening Pennsylvania beginn...
Read More >
Corporate, social and responsibility (CSR): three words when spoken together ought to mean something...
Read More >
The Occupational Safety and Health Administration (“OSHA”) issued a May 15th news release stating ...
Read More >